Aimmune Therapeutics reports 3Q loss Mon, 06 Nov 2017 13:37:31 +0000 On a per-share basis, the Brisbane, California-based company said it had a loss of 63 cents. The results beat Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment ...
Aimmune Therapeutics to Participate in Four Investor Conferences in November Wed, 01 Nov 2017 12:00:00 +0000 Aimmune Therapeutics, Inc. , a biopharmaceutical company developing treatments for life-threatening food allergies, today announced that members of the Aimmune executive management team will participate in four upcoming investor conferences in November.
DBV Technologies’ Pain is Aimmune Therapeutics Inc’s (AIMT) Gain Mon, 23 Oct 2017 17:46:27 +0000 It's a very rewarding trading day for Aimmune Therapeutics Inc (NASDAQ:AIMT) investors with shares up over 30%, making the stock Wall Street's bull of the day. The reason? The allergy medicine maker benefited from the news that its competitor DBV Technologies SA - ADR (NASDAQ:DBVT) reported disappointing late-stage clinical trial results for its experimental treatment, Viaskin Peanut, a patch designed to enhance protection of peanut allergic children.
DBV Shares Fall After Phase 3 Data on Peanut Allergy Treatment -- Biotech Movers Mon, 23 Oct 2017 13:15:00 +0000 The Montrouge, France-based firm on Friday unveiled top-line results from its Phase 3 study of a peanut allergy treatment. The study, dubbed Pepites, evaluated Viaskin Peanut in children four to 11 years ...
*Winners defined as our Top Picks that increased 20% or more within a 6-month period.
Red Letters imply that that particular criteria did not meet minimum requirements, e.g., a low GSA Rank would show it in red.
___ Red Line On Graph Shows a Trailing Stop Loss Based on Support and Resistance Levels. See how it works.
___ Blue Line On Graph Shows the 10-Week Moving Average.
___ Magenta Line On Graph Shows the 40-Week Moving Average.
Disclaimer The stock selections in our stock investing and stock trading database are not stock recommendations, but simply represent applications of a stock investing process. All materials, including our Top Stock Picks, are provided for information purposes only and should not be used or construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security. Growth Stock Analytics, LLC is not responsible for gains/losses that may result in investing or trading in these securities. All information is believed to be obtained from reliable sources, but there is no guarantee that the information supplied is accurate, complete or timely. There is no guarantee or warranty with regard to the results obtained from its use. There is no guarantee of suitability or potential value of any particular investment or information source. You acknowledge that your requests for this information are unsolicited and shall neither constitute nor be considered investment advice. Past investing performance is not an indication of future performance results. Investing and trading in stocks is risky. Investors are encouraged to consult a registered stock broker or investment adviser before making any investing decisions. The interpretations and opinions expressed herein are solely those of Growth Stock Analytics, LLC, and not of any other individual or organization.
Accum/Dist: 1.92 (median winner: 1.53)
Instit. Ownership: 73% (median winner: 63%)
Disclaimer The stock selections in our stock investing and stock trading database are not stock recommendations, but simply represent applications of a stock investing process. All materials, including our Top Stock Picks, are provided for information purposes only and should not be used or construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security. Growth Stock Analytics, LLC is not responsible for gains/losses that may result in investing or trading in these securities. All information is believed to be obtained from reliable sources, but there is no guarantee that the information supplied is accurate, complete or timely. There is no guarantee or warranty with regard to the results obtained from its use. There is no guarantee of suitability or potential value of any particular investment or information source. You acknowledge that your requests for this information are unsolicited and shall neither constitute nor be considered investment advice. Past investing performance is not an indication of future performance results. Investing and trading in stocks is risky. Investors are encouraged to consult a registered stock broker or investment adviser before making any investing decisions. The interpretations and opinions expressed herein are solely those of Growth Stock Analytics, LLC, and not of any other individual or organization.